research use only
Cat.No.S7862
|
In vitro |
DMSO
: 11 mg/mL
(21.29 mM)
Ethanol : 1 mg/mL Water : ˂1 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 516.54 | Formula | C30H28O8 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 82-08-6 | -- | Storage of Stock Solutions |
|
|
| Synonyms | Mallotoxin, NSC 56346, NSC 94525 | Smiles | CC1=C(C(=C(C(=C1O)C(=O)C)O)CC2=C(C(=C3C(=C2O)C=CC(O3)(C)C)C(=O)C=CC4=CC=CC=C4)O)O | ||
| Targets/IC50/Ki |
PKCδ
(Cell-free assay) 3 μM
CKIII
(Cell-free assay) 5.3 μM
PKCα
(Cell-free assay) 30 μM
CKII
(Cell-free assay) 30 μM
PKCγ
(Cell-free assay) 40 μM
PKCβ
(Cell-free assay) 42 μM
PKA
(Cell-free assay) 78 μM
PKCη
(Cell-free assay) 82 μM
|
|---|---|
| In vitro |
Rottlerin is extracted from the plasma and tissues using protein precipitation-extraction and analyzed by reverse-phase HPLC-DAD method. Significant levels of this compound are detected in cell lysates from rottlerin-treated HPAF-II cells. These data indicate that it is efficiently absorbed in cells in vitro. |
| In vivo |
A xenograft model of pancreatic cancer is prepared by injection of 2×106 HPAF-II cells subcutaneously into nude mice. A substantial amount of this compound is detected in tumor and plasma in mice fed this compound diet. These data indicate that this compound is efficiently absorbed in vivo and suggest a strong potential for this compound as a preventive or adjuvant supplement for pancreatic cancer. |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.